Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | PHAT | HUMA | ||
| Company | Urovant Sciences Ltd | Phathom Pharmaceuticals Inc | Humacyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 9.46 | 4.50 | ||
| High | 16.24 | 9.84 | 4.55 | ||
| Low | 16.21 | 9.36 | 4.28 | ||
| Last | 16.24 | 9.55 | 4.40 | ||
| Change | +0.01 | +0.29 | -0.01 | ||
| % Change | +0.06% | +3.13% | -0.23% | ||
| Volume | 1,739,000 | 453,040 | 625,163 | ||
| 20-Day Average Volume | 143,510 | 688,296 | 1,686,370 | ||
| Previous Close | 16.23 | 9.26 | 4.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 9.89 | 3.53 | ||
| 20-Day Raw Stochastic | 87.10% | 30.74% | 89.74% | ||
| 20-Day Relative Strength | 65.56% | 52.02% | 65.87% | ||
| Weighted Alpha | +6.45 | -36.78 | +23.29 | ||
| Today's Opinion | 100% Buy | 16% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | Hold | 88% Buy | ||
| Last Month's Opinion | 96% Buy | 24% Buy | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +7.97% since 04/25/24 | +12.44% since 04/25/24 | ||
| Low | 16.20 on 03/24/21 | 8.95 on 04/29/24 | 3.85 on 04/26/24 | ||
| High | 16.25 on 03/25/21 | 9.84 on 05/02/24 | 4.57 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +0.26% since 04/02/24 | +47.64% since 04/02/24 | ||
| Low | 16.10 on 03/02/21 | 8.74 on 04/25/24 | 2.81 on 04/12/24 | ||
| High | 16.26 on 03/19/21 | 12.27 on 04/09/24 | 4.57 on 05/01/24 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +41.98% since 02/02/24 | +32.88% since 02/02/24 | ||
| Low | 16.03 on 12/30/20 | 6.07 on 02/13/24 | 2.81 on 04/12/24 | ||
| High | 16.26 on 03/19/21 | 12.27 on 04/09/24 | 4.86 on 02/20/24 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +23.12% since 11/02/23 | +107.82% since 11/02/23 | ||
| Low | 7.15 on 11/02/20 | 6.07 on 02/13/24 | 2.08 on 11/10/23 | ||
| High | 16.26 on 03/19/21 | 12.27 on 04/09/24 | 4.86 on 02/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 541,932 | 523,970 | ||
| Shares Outstanding, K | 32,743 | 58,524 | 119,084 | ||
| Annual Sales | 0 | 680,000 | 0 | ||
| Annual Net Income | -146,750,000 | -201,590,000 | -110,780,000 | ||
| Last Quarter Sales | 0 | 680,000 | 0 | ||
| Last Quarter Net Income | -46,800,000 | -79,570,000 | -25,110,000 | ||
| 60-Month Beta | 2.35 | 0.67 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.80 on 03/07/24 | -0.24 on 03/22/24 | ||
| Latest Earnings Date | 02/11/21 | 05/09/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||